User profiles for Philipp Sewerin
 | PD Dr. Dr. Philipp SewerinUniklinik Bochum, Rheumazentrum Ruhrgebiet Verified email at hhu.de Cited by 1300 |
[HTML][HTML] German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS)
Background: Chronic rheumatic diseases need long-term treatment and professional supervision.
Mobile apps promise to improve the lives of patients and physicians. In routine practice…
Mobile apps promise to improve the lives of patients and physicians. In routine practice…
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey
Objective To analyse the impact of the COVID-19 pandemic on rheumatic patients’ and
rheumatologists’ usage, preferences and perception of digital health applications (DHAs). …
rheumatologists’ usage, preferences and perception of digital health applications (DHAs). …
Prevalence and incidence of psoriasis and psoriatic arthritis
Psoriasis (Pso) and psoriatic arthritis (PsA) are inflammatory disorders which can severely
impair health and quality of life. For both Pso and PsA, an increasing prevalence has been …
impair health and quality of life. For both Pso and PsA, an increasing prevalence has been …
[HTML][HTML] Understanding and minimising injection-site pain following subcutaneous administration of biologics: a narrative review
…, F Prignano, J Goncalves, M Paul, P Sewerin - Rheumatology and …, 2020 - Springer
Injection-site pain (ISP) is a subjective side effect that is commonly reported with the
subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple …
subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple …
[HTML][HTML] Acceptance, usage, and barriers of electronic patient-reported outcomes among German rheumatologists: survey study
Background: The use of patient-reported outcomes (PROs) allows for patient-centered,
measurable, and transparent care. Electronic PROs (ePROs) have many benefits and hold great …
measurable, and transparent care. Electronic PROs (ePROs) have many benefits and hold great …
[HTML][HTML] Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort
Background Remission is arguably the ultimate therapeutic goal in rheumatoid arthritis (RA).
Applying modern strategies, clinical remission can be achieved in a substantial number of …
Applying modern strategies, clinical remission can be achieved in a substantial number of …
Patients' awareness towards physical activity in the treatment of axial spondyloarthritis
…, L Schneider, I Andreica, B Buehring, P Sewerin… - Joint Bone Spine, 2023 - Elsevier
Introduction The course of axial spondyloarthritis (axSpA) is often characterized by
impairments in physical function and mobility. Regular physical activity (PA) is a cornerstone of …
impairments in physical function and mobility. Regular physical activity (PA) is a cornerstone of …
[HTML][HTML] Dynamic contrast-enhanced magnetic resonance imaging of metacarpophalangeal joints reflects histological signs of synovitis in rheumatoid arthritis
…, C Schleich, T Lögters, P Sewerin… - Arthritis research & …, 2014 - Springer
Introduction Synovial inflammation and joint destruction in rheumatoid arthritis (RA) may
progress despite clinical remission. Dynamic contrast-enhanced magnetic resonance imaging (…
progress despite clinical remission. Dynamic contrast-enhanced magnetic resonance imaging (…
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial
F Behrens, P Sewerin, E de Miguel, Y Patel… - …, 2022 - academic.oup.com
Objective ACHILLES aimed to demonstrate efficacy of secukinumab on Achilles’ tendon
enthesitis in spondyloarthritis (SpA) patients. Methods Patients ≥18 years (n = 204) with active …
enthesitis in spondyloarthritis (SpA) patients. Methods Patients ≥18 years (n = 204) with active …
Glycosaminoglycan chemical exchange saturation transfer of lumbar intervertebral discs in patients with spondyloarthritis
…, A Müller‐Lutz, F Matuschke, P Sewerin… - Journal of Magnetic …, 2015 - Wiley Online Library
Purpose To assess glycosaminoglycan (GAG) content of lumbar intervertebral discs (IVD) in
patients with spondyloarthritis (SpA) using glycosaminoglycan chemical exchange …
patients with spondyloarthritis (SpA) using glycosaminoglycan chemical exchange …